Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...
6d
GlobalData on MSNBavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teensBavarian Nordic sets up a bout with Valneva’s Ixchiq, the former’s Vimkunya already having an edge in population reach.
The FDA has approved Bavarian Nordic’s Vimkunya, the first virus-like particle (VLP) chikungunya vaccine for patients over 12 years of age. According to the company, approval was based on strong ...
This approval marks the official ... to generate orthogonal reformats. (FDA-Cleared) Subtle Medical was the first to market with third-party AI-powered image enhancement software solutions with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results